Form 4: NSV Partners III LP Reports Distribution of Ventyx Biosciences Shares

NSV Partners III LP reports the distribution of Ventyx Biosciences (VTYX) shares to its limited partners, resulting in a change in beneficial ownership.

Summary

• On June 24, 2024, NSV Partners III LP reported a transaction involving Ventyx Biosciences, Inc. (VTYX) common stock.
• The transaction involved the distribution of shares to the limited partners of NSV Investments I, L.P., NSV Investments II, L.P., and NSV Investments III, L.P.
• NSV Investments I, L.P. distributed 125,651 shares, NSV Investments II, L.P. distributed 232,180 shares, and NSV Investments III, L.P. distributed 283,496 shares.
• Following the transaction, NSV Partners III LP indirectly beneficially owns 7,102,969 shares.
• The reporting persons include NSV Partners III LP and NSV Partners III GP LLC, with Somasundaram Subramaniam having voting and dispositive power over the shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment. It reports a distribution of shares, which doesn't inherently suggest positive or negative implications for the company's performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders, providing transparency to the market regarding significant shareholders' activities.

Stakeholder Impact

• Shareholders may be interested in the changes in ownership structure, although the distribution itself doesn't necessarily indicate a change in the company's fundamentals.

Key Dates